Skip to main content
Top
Published in: Neurocritical Care 1/2009

01-02-2009 | Practical Pearl

Intravenous Levetiracetam Terminates Refractory Focal Status Epilepticus

Authors: Nicholas S. Abend, Nicole Florance, Richard S. Finkel, Daniel J. Licht, Dennis J. Dlugos

Published in: Neurocritical Care | Issue 1/2009

Login to get access

Abstract

Discussion

We report a 23-year-old with complex partial status epilepticus, possibly related to underlying stroke-like migraine attacks after radiation therapy syndrome, that was refractory to benzodiazepines and phenytoin but was terminated by administration of intravenous levetiracetam.
Literature
1.
go back to reference Lowenstein DH. The management of refractory status epilepticus: an update. Epilepsia 2006;47 Suppl 1:35–40.PubMedCrossRef Lowenstein DH. The management of refractory status epilepticus: an update. Epilepsia 2006;47 Suppl 1:35–40.PubMedCrossRef
2.
go back to reference Holtkamp M. The anaesthetic and intensive care of status epilepticus. Curr Opin Neurol 2007;20:188–93.PubMedCrossRef Holtkamp M. The anaesthetic and intensive care of status epilepticus. Curr Opin Neurol 2007;20:188–93.PubMedCrossRef
3.
go back to reference Ramael S, Daoust A, Otoul C, Toublanc N, Troenaru M, Lu ZS, Stockis A. Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study. Epilepsia 2006;47:1128–35.PubMedCrossRef Ramael S, Daoust A, Otoul C, Toublanc N, Troenaru M, Lu ZS, Stockis A. Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study. Epilepsia 2006;47:1128–35.PubMedCrossRef
4.
go back to reference Ramael S, De Smedt F, Toublanc N, Otoul C, Boulanger P, Riethuisen JM, Stockis A. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects. Clin Ther 2006;28:734–44.PubMedCrossRef Ramael S, De Smedt F, Toublanc N, Otoul C, Boulanger P, Riethuisen JM, Stockis A. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects. Clin Ther 2006;28:734–44.PubMedCrossRef
5.
go back to reference Rupprecht S, Franke K, Fitzek S, Witte OW, Hagemann G. Levetiracetam as a treatment option in non-convulsive status epilepticus. Epilepsy Res 2007;73:238–44.PubMedCrossRef Rupprecht S, Franke K, Fitzek S, Witte OW, Hagemann G. Levetiracetam as a treatment option in non-convulsive status epilepticus. Epilepsy Res 2007;73:238–44.PubMedCrossRef
6.
go back to reference Patel NC, Landan IR, Levin J, Szaflarski J, Wilner AN. The use of levetiracetam in refractory status epilepticus. Seizure 2006;15:137–41.PubMedCrossRef Patel NC, Landan IR, Levin J, Szaflarski J, Wilner AN. The use of levetiracetam in refractory status epilepticus. Seizure 2006;15:137–41.PubMedCrossRef
7.
go back to reference Rossetti AO, Bromfield EB. Levetiracetam in the treatment of status epilepticus in adults: a study of 13 episodes. Eur Neurol 2005;54:34–8.PubMedCrossRef Rossetti AO, Bromfield EB. Levetiracetam in the treatment of status epilepticus in adults: a study of 13 episodes. Eur Neurol 2005;54:34–8.PubMedCrossRef
8.
go back to reference Rossetti AO, Bromfield EB. Determinants of success in the use of oral levetiracetam in status epilepticus. Epilepsy Behav 2006;8:651–4.PubMedCrossRef Rossetti AO, Bromfield EB. Determinants of success in the use of oral levetiracetam in status epilepticus. Epilepsy Behav 2006;8:651–4.PubMedCrossRef
9.
go back to reference Schulze-Bonhage A, Hefft S, Oehl B. Termination of complex partial status epilepticus by intravenous levetiracetam—a case report. J Neurol Neurosurg Psychiatry 2007 [Epub ahead of print, March 12, 2007]. Schulze-Bonhage A, Hefft S, Oehl B. Termination of complex partial status epilepticus by intravenous levetiracetam—a case report. J Neurol Neurosurg Psychiatry 2007 [Epub ahead of print, March 12, 2007].
10.
go back to reference Stefan H, Wang-Tilz Y, Pauli E, Dennhofer S, Genow A, Kerling F, Lorber B, Fraunberger B, Halboni P, Koebnick C, Gefeller O, Tilz C. Onset of action of levetiracetam: a RCT trial using therapeutic intensive seizure analysis (TISA). Epilepsia 2006;47:516–22.PubMedCrossRef Stefan H, Wang-Tilz Y, Pauli E, Dennhofer S, Genow A, Kerling F, Lorber B, Fraunberger B, Halboni P, Koebnick C, Gefeller O, Tilz C. Onset of action of levetiracetam: a RCT trial using therapeutic intensive seizure analysis (TISA). Epilepsia 2006;47:516–22.PubMedCrossRef
11.
go back to reference French J, Arrigo C. Rapid onset of action of levetiracetam in refractory epilepsy patients. Epilepsia 2005;46:324–6.PubMedCrossRef French J, Arrigo C. Rapid onset of action of levetiracetam in refractory epilepsy patients. Epilepsia 2005;46:324–6.PubMedCrossRef
12.
go back to reference Black DF, Bartleson JD, Bell ML, Lachance DH. SMART: stroke-like migraine attacks after radiation therapy. Cephalalgia 2006;26:1137–42.PubMedCrossRef Black DF, Bartleson JD, Bell ML, Lachance DH. SMART: stroke-like migraine attacks after radiation therapy. Cephalalgia 2006;26:1137–42.PubMedCrossRef
13.
go back to reference Pruitt A, Dalmau J, Detre J, Alavi A, Rosenfeld MR. Episodic neurologic dysfunction with migraine and reversible imaging findings after radiation. Neurology 2006;67:676–8.PubMedCrossRef Pruitt A, Dalmau J, Detre J, Alavi A, Rosenfeld MR. Episodic neurologic dysfunction with migraine and reversible imaging findings after radiation. Neurology 2006;67:676–8.PubMedCrossRef
14.
go back to reference Hormigo A, Liberato B, Lis E, DeAngelis LM. Nonconvulsive status epilepticus in patients with cancer: imaging abnormalities. Arch Neurol 2004;61:362–5.PubMedCrossRef Hormigo A, Liberato B, Lis E, DeAngelis LM. Nonconvulsive status epilepticus in patients with cancer: imaging abnormalities. Arch Neurol 2004;61:362–5.PubMedCrossRef
15.
go back to reference Lansberg MG, O’Brien MW, Norbash AM, Moseley ME, Morrell M, Albers GW. MRI abnormalities associated with partial status epilepticus. Neurology 1999;52:1021–7.PubMed Lansberg MG, O’Brien MW, Norbash AM, Moseley ME, Morrell M, Albers GW. MRI abnormalities associated with partial status epilepticus. Neurology 1999;52:1021–7.PubMed
Metadata
Title
Intravenous Levetiracetam Terminates Refractory Focal Status Epilepticus
Authors
Nicholas S. Abend
Nicole Florance
Richard S. Finkel
Daniel J. Licht
Dennis J. Dlugos
Publication date
01-02-2009
Publisher
Humana Press Inc
Published in
Neurocritical Care / Issue 1/2009
Print ISSN: 1541-6933
Electronic ISSN: 1556-0961
DOI
https://doi.org/10.1007/s12028-007-9044-9

Other articles of this Issue 1/2009

Neurocritical Care 1/2009 Go to the issue